CareFirst BlueCross BlueShield

Scene Health and CareFirst Expand Partnership for Medicaid Members

Retrieved on:

木曜日, 3月 21, 2024

Scene Health (Scene) and CareFirst BlueCross BlueShield (CareFirst), one of the country’s largest not-for-profit healthcare organizations, are proud to announce the expansion of their partnership.

Key Points:

Scene Health (Scene) and CareFirst BlueCross BlueShield (CareFirst), one of the country’s largest not-for-profit healthcare organizations, are proud to announce the expansion of their partnership.
“Our partnership with Scene has helped deepen our understanding of the real-life experiences and challenges members were facing,” said Mike Rapach, President and CEO of CareFirst Community Health Plan Maryland (CHPMD).
“We are grateful for five years of outstanding partnership with CareFirst BlueCross BlueShield of Maryland’s Medicaid team.
“Innovations such as Scene Health's services seamlessly coordinated with other CareFirst health services, benefits, and rich network coverage are critical for us to improve the overall health and quality of care for our members."

Healthcare Innovation Company Announces Investor-Led Panels on the Latest Trends for Healthcare, Navigating Generative AI at Its Annual thINc360 Event, May 29-31, in D.C.

Retrieved on:

木曜日, 3月 7, 2024

Flare, EVP, Independence Blue Cross, Gen, General partnership, CareFirst BlueCross BlueShield, Venture capital, Content, Corporate development, Ecosystem, Partner (business rank), Congress, IBX, CIO

NEEDHAM, Mass., March 7, 2024 /PRNewswire-PRWeb/ --The Healthcare Innovation Company announced the addition of more investor perspectives at its upcoming thINc360 event, taking place May 29-31, in Washington, D.C, including:

Key Points:

While so much of the recent buzz is centered on generative AI, and rightly so, there is so much more to explore when it comes to other investment opportunities and evaluating practical next steps with new technologies and burgeoning solutions.
We are excited to bring the investor and startup communities together in a large forum and continue our mission to further innovation in healthcare," said Haritha Krishnarathnam, EVP of Strategy and Content, at The Healthcare Innovation Company.
Additional investor insights at thINc360 will be delivered by:
Endeavor Venture Funds & Venture Studio, Managing Partner and CIO, Martin Alexander Gershon
Early registration deadlines are in effect, with the next one expiring on Friday, March 15.
Prospective attendees and sponsors are encouraged to visit https://www.thinc360.com/2024event for more information.

Vitality Appoints Distinguished Health Plan Executive Steve Margolis as President

Retrieved on:

木曜日, 2月 8, 2024

Biotechnology, General Health, Health, Mental Health, Vitality, CareFirst BlueCross BlueShield, Running, Growth, Global health, Health care, Medicare, Organization, Medicaid, Patient, ACA, Management

Vitality Group , a global health and wellbeing company specializing in behavior change, announced the appointment of senior health plan strategist Steve Margolis to its executive staff as President to accelerate and grow its foothold in the market.

Key Points:

Vitality Group , a global health and wellbeing company specializing in behavior change, announced the appointment of senior health plan strategist Steve Margolis to its executive staff as President to accelerate and grow its foothold in the market.
Margolis is a C-suite executive with over 30 years of experience running, building, and growing healthcare services organizations at both national for-profit and regional not-for-profit health plans, health tech companies and population health organizations.
In his role at Vitality, Margolis will help define, shape and execute Vitality’s strategic initiatives, brand recognition, product evolution and profitability objectives.
In keeping with its core purpose to make people healthier, the strategic focus is fast tracking growth in the U.S. health plan market.

MRO Is Among Latest to Earn Validated Data Stream Designations in NCQA Data Aggregator Validation Program, For Third Time

Retrieved on:

水曜日, 1月 24, 2024

Certification, CareFirst BlueCross BlueShield, Quality assurance, NCQA, Trust, Electronic health record, National Committee, MRO, Health, Directory, Medical device

NORRISTOWN, Pa., Jan. 24, 2024 /PRNewswire/ -- MRO, Corp. (MRO), the leading clinical data exchange company in healthcare, announced today that it has earned the Validated Data Stream designation in the National Committee for Quality Assurance (NCQA) Data Aggregator Validation program. It is part of the latest NCQA cohort to earn the NCQA validation.

Key Points:

(MRO), the leading clinical data exchange company in healthcare, announced today that it has earned the Validated Data Stream designation in the National Committee for Quality Assurance (NCQA) Data Aggregator Validation program.
It is part of the latest NCQA cohort to earn the NCQA validation.
From ingestion at primary sources through transmission to end users, validated data streams adhere to NCQA process, system and data standards.
FIGmd, an MRO company, is listed as the entity earning the Validated Data Stream designation on the NCQA directory.

NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer

Retrieved on:

水曜日, 12月 20, 2023

Policy, Indigestion, Neuraxis, FDA, Medical classification, RED, University, Insurance, Letter, IPO, Constipation, Publication, CareFirst BlueCross BlueShield

As we look back at the first 120 days since our IPO, we are very pleased with our accomplishments.

Key Points:

As we look back at the first 120 days since our IPO, we are very pleased with our accomplishments.
Highly successful med-tech companies build success from the foundation of strong data publications, which leads to broad insurance policy coverage which results in exponential revenue growth.
The primary goal in the 4th quarter was to make sure the publications were in place to confidently ask insurance companies for written policy coverage, and we have succeeded.
We have now executed and delivered one of the strongest med-tech research publication portfolios in the industry.

NeurAxis Reports Third Quarter 2023 Financial Results

Retrieved on:

月曜日, 11月 20, 2023

Policy, Adolescence, Research, Neuraxis, Percutaneous, Hospital, Record, Abdominal pain, RED, Disability, University, Cyproheptadine, Growth, Publication, Patient, CareFirst BlueCross BlueShield, Amitriptyline, FAPD, Video game

CARMEL, Ind., Nov. 20, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NYSE American: NRXS) (“NeurAxis” or the “Company”), a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children and adults, today reported financial results for the third quarter ended September 30, 2023.

Key Points:

CARMEL, Ind., Nov. 20, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NYSE American: NRXS) (“NeurAxis” or the “Company”), a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children and adults, today reported financial results for the third quarter ended September 30, 2023.
Gross margin totaled 85.9% in the third quarter of 2023, compared to 89.1% in the third quarter of 2022.
Selling expenses for the third quarter of 2023 were $64.2 thousand, compared to $81.6 thousand in the third quarter of 2022.
General and administrative expenses for the third quarter of 2023 were $3,323.4 thousand, compared to $1,586.5 thousand in the third quarter of 2022.

NeurAxis Announces CareFirst BCBS Policy Coverage

Retrieved on:

水曜日, 11月 15, 2023

Neuraxis, NYSE, Policy, CareFirst BlueCross BlueShield, Health insurance

CARMEL, Ind., Nov. 15, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced receipt of CareFirst Blue Cross Blue Shield (“CareFirst BCBS”) policy coverage for the mid-Atlantic region with 3.5 million lives.

Key Points:

CARMEL, Ind., Nov. 15, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced receipt of CareFirst Blue Cross Blue Shield (“CareFirst BCBS”) policy coverage for the mid-Atlantic region with 3.5 million lives.
CareFirst BCBS is the largest healthcare insurer in the mid-Atlantic that includes Maryland, Washington DC, and Northern Virginia.
“We are pleased to announce new policy coverage from CareFirst BCBS, which is in line with our strategy to leverage clinical evidence supporting IB-Stim™ to obtain payer coverage and then drive market adoption of our technology,” said Brian Carrico, President and Chief Executive Officer of NeurAxis.
“With CareFirst BCBS, our covered lives now stands at 8.25 million and we look forward to receiving positive response from payers on a national level as we close in on all data being published.”

HiLabs Grows Product Delivery Leadership With Sumeet Seth and Harsh Vardhan

Retrieved on:

火曜日, 11月 7, 2023

Centene Corporation, Inovalon, Bank, SVP, CareFirst BlueCross BlueShield, Multimedia, Growth, Bank of America, Deutsche Bank, Prudential, AI, Management, Jilab, Shashi Sumeet Productions

BETHESDA, Md., Nov. 7, 2023 /PRNewswire/ -- HiLabs, maker of the healthcare data AI engine MCheck, announced it has added two leadership positions to its Product Delivery team. Sumeet Seth joins as SVP and Head of Product Delivery, along with Harsh Vardhan as VP of Product Delivery.

Key Points:

BETHESDA, Md., Nov. 7, 2023 /PRNewswire/ -- HiLabs, maker of the healthcare data AI engine MCheck, announced it has added two leadership positions to its Product Delivery team.
Sumeet Seth joins as SVP and Head of Product Delivery, along with Harsh Vardhan as VP of Product Delivery.
"I am delighted to welcome Sumeet and Harsh as HiLabs enters a period of rapid growth and ahead of new product innovations on the horizon.
Sumeet brings over 20 years of expertise in managing product strategy in technology-driven healthcare and finance firms to his new role at HiLabs.

OZ Digital Consulting's Dynamic New SVP of Digital Solutions is Focused on Future

Retrieved on:

木曜日, 10月 19, 2023

"It's very exciting to introduce such a dynamic talent to the OZ leadership team," OZ Chief Solutions Officer Emmanuel Ramos said.

Key Points:

"It's very exciting to introduce such a dynamic talent to the OZ leadership team," OZ Chief Solutions Officer Emmanuel Ramos said.
"Steve brings a wealth of experience in strategic technology leadership and business growth, with a focus on driving digital transformation.
"I am thrilled to join OZ because of the company's unwavering commitment to innovation and excellence," Bakanov says.
To learn more about the wide range of digital consulting services, visit our website .

SafeRide Health Continues Growth in Improving Access to Life-Sustaining Care with Series C Funding

Retrieved on:

金曜日, 10月 6, 2023

SafeRide’s successful Series C demonstrates strong support for the firm’s vision, technology, and team to disrupt the $10+ billion non-emergency medical transportation (NEMT) market.

Key Points:

SafeRide’s successful Series C demonstrates strong support for the firm’s vision, technology, and team to disrupt the $10+ billion non-emergency medical transportation (NEMT) market.
Last year, more than one in five adults without access to transportation reported missing necessary, often life sustaining, medical care.
They’re at the forefront of transforming access to care for our nation’s most vulnerable populations,” said Michael Graninger, Managing Partner, at Sands Capital.
“Thoughtfully meeting social needs, like transportation, means members are more likely to engage with their care plan and may achieve better health outcomes.”